nodes	percent_of_prediction	percent_of_DWPC	metapath
Dopamine—SLC22A1—hematologic cancer	0.192	1	CbGaD
Dopamine—L-DOPA—Melphalan—hematologic cancer	0.163	1	CrCrCtD
Dopamine—SLC22A3—Melphalan—hematologic cancer	0.0494	0.119	CbGbCtD
Dopamine—SLC22A2—Daunorubicin—hematologic cancer	0.0207	0.0498	CbGbCtD
Dopamine—SLC22A2—Cytarabine—hematologic cancer	0.0182	0.0439	CbGbCtD
Dopamine—SLC22A2—Cladribine—hematologic cancer	0.0172	0.0415	CbGbCtD
Dopamine—SLC22A3—Irinotecan—hematologic cancer	0.0167	0.0403	CbGbCtD
Dopamine—SLC22A1—Cytarabine—hematologic cancer	0.0158	0.0382	CbGbCtD
Dopamine—SLC22A2—Imatinib—hematologic cancer	0.0158	0.0382	CbGbCtD
Dopamine—CYP1A2—Anagrelide—hematologic cancer	0.0155	0.0373	CbGbCtD
Dopamine—SLC22A1—Cladribine—hematologic cancer	0.015	0.036	CbGbCtD
Dopamine—SLC22A3—Vincristine—hematologic cancer	0.0146	0.0352	CbGbCtD
Dopamine—SLC22A1—Imatinib—hematologic cancer	0.0138	0.0331	CbGbCtD
Dopamine—CYP2C9—Bexarotene—hematologic cancer	0.00967	0.0233	CbGbCtD
Dopamine—SLC22A2—Vinblastine—hematologic cancer	0.00879	0.0212	CbGbCtD
Dopamine—CYP2D6—Lomustine—hematologic cancer	0.00822	0.0198	CbGbCtD
Dopamine—CYP1A2—Carmustine—hematologic cancer	0.00813	0.0196	CbGbCtD
Dopamine—SLC22A2—Cisplatin—hematologic cancer	0.00806	0.0194	CbGbCtD
Dopamine—CYP2C9—Idarubicin—hematologic cancer	0.00801	0.0193	CbGbCtD
Dopamine—CYP2D6—Idarubicin—hematologic cancer	0.00733	0.0177	CbGbCtD
Dopamine—CYP2C19—Bortezomib—hematologic cancer	0.00713	0.0172	CbGbCtD
Dopamine—CYP1A2—Methoxsalen—hematologic cancer	0.00692	0.0167	CbGbCtD
Dopamine—CYP1A2—Bortezomib—hematologic cancer	0.00658	0.0159	CbGbCtD
Dopamine—CYP1A2—Daunorubicin—hematologic cancer	0.00629	0.0152	CbGbCtD
Dopamine—CYP2D6—Hydroxyurea—hematologic cancer	0.00623	0.015	CbGbCtD
Dopamine—CYP2C19—Thalidomide—hematologic cancer	0.00621	0.015	CbGbCtD
Dopamine—CYP1A2—Alitretinoin—hematologic cancer	0.00616	0.0149	CbGbCtD
Dopamine—CYP2C9—Bortezomib—hematologic cancer	0.00593	0.0143	CbGbCtD
Dopamine—CYP2C19—Teniposide—hematologic cancer	0.00592	0.0143	CbGbCtD
Dopamine—CYP1A2—Thalidomide—hematologic cancer	0.00573	0.0138	CbGbCtD
Dopamine—CYP2C19—Ifosfamide—hematologic cancer	0.00547	0.0132	CbGbCtD
Dopamine—CYP2D6—Bortezomib—hematologic cancer	0.00542	0.0131	CbGbCtD
Dopamine—CYP2C19—Imatinib—hematologic cancer	0.00522	0.0126	CbGbCtD
Dopamine—CYP2C9—Thalidomide—hematologic cancer	0.00516	0.0124	CbGbCtD
Dopamine—CYP1A2—Dacarbazine—hematologic cancer	0.00493	0.0119	CbGbCtD
Dopamine—CYP2C9—Teniposide—hematologic cancer	0.00493	0.0119	CbGbCtD
Dopamine—CYP1A2—Imatinib—hematologic cancer	0.00482	0.0116	CbGbCtD
Dopamine—CYP2C9—Ifosfamide—hematologic cancer	0.00455	0.011	CbGbCtD
Dopamine—CYP2C9—Imatinib—hematologic cancer	0.00434	0.0105	CbGbCtD
Dopamine—CYP2D6—Imatinib—hematologic cancer	0.00397	0.00957	CbGbCtD
Dopamine—CYP2C9—Nilotinib—hematologic cancer	0.00395	0.00951	CbGbCtD
Dopamine—CYP1A2—Dasatinib—hematologic cancer	0.00387	0.00933	CbGbCtD
Dopamine—CYP2D6—Nilotinib—hematologic cancer	0.00361	0.0087	CbGbCtD
Dopamine—CYP2D6—Vinorelbine—hematologic cancer	0.00358	0.00862	CbGbCtD
Dopamine—CYP2C19—Prednisone—hematologic cancer	0.00344	0.00829	CbGbCtD
Dopamine—CYP1A2—Etoposide—hematologic cancer	0.00241	0.00581	CbGbCtD
Dopamine—CYP2C9—Cisplatin—hematologic cancer	0.00221	0.00533	CbGbCtD
Dopamine—CYP2D6—Vinblastine—hematologic cancer	0.00221	0.00531	CbGbCtD
Dopamine—CYP2C19—Dexamethasone—hematologic cancer	0.00215	0.00518	CbGbCtD
Dopamine—CYP2C9—Dexamethasone—hematologic cancer	0.00179	0.0043	CbGbCtD
Dopamine—CYP2D6—Dexamethasone—hematologic cancer	0.00163	0.00394	CbGbCtD
Dopamine—DBH—hematopoietic system—hematologic cancer	0.00158	0.0532	CbGeAlD
Dopamine—CYP2D6—Doxorubicin—hematologic cancer	0.00135	0.00327	CbGbCtD
Dopamine—L-DOPA—PSIP1—hematologic cancer	0.00127	0.361	CrCbGaD
Dopamine—DRD5—hematopoietic system—hematologic cancer	0.00121	0.0409	CbGeAlD
Dopamine—DBH—blood—hematologic cancer	0.00105	0.0352	CbGeAlD
Dopamine—DBH—bone marrow—hematologic cancer	0.00101	0.0341	CbGeAlD
Dopamine—DRD4—testis—hematologic cancer	0.00101	0.034	CbGeAlD
Dopamine—COMT—hematopoietic system—hematologic cancer	0.000834	0.0281	CbGeAlD
Dopamine—Isoprenaline—PIK3R1—hematologic cancer	0.000786	0.224	CrCbGaD
Dopamine—SLC6A3—hematopoietic system—hematologic cancer	0.000745	0.0251	CbGeAlD
Dopamine—SLC22A3—hematopoietic system—hematologic cancer	0.000701	0.0236	CbGeAlD
Dopamine—SLC6A4—hematopoietic system—hematologic cancer	0.000683	0.023	CbGeAlD
Dopamine—MAOB—hematopoietic system—hematologic cancer	0.000649	0.0219	CbGeAlD
Dopamine—COMT—gonad—hematologic cancer	0.000634	0.0214	CbGeAlD
Dopamine—DBH—lymph node—hematologic cancer	0.000627	0.0211	CbGeAlD
Dopamine—HTR1A—hematopoietic system—hematologic cancer	0.000606	0.0204	CbGeAlD
Dopamine—HTR7—hematopoietic system—hematologic cancer	0.000579	0.0195	CbGeAlD
Dopamine—CYP2C19—hematopoietic system—hematologic cancer	0.000566	0.0191	CbGeAlD
Dopamine—MAOA—hematopoietic system—hematologic cancer	0.000554	0.0187	CbGeAlD
Dopamine—COMT—blood—hematologic cancer	0.000553	0.0186	CbGeAlD
Dopamine—COMT—bone marrow—hematologic cancer	0.000535	0.018	CbGeAlD
Dopamine—SLC22A3—gonad—hematologic cancer	0.000533	0.018	CbGeAlD
Dopamine—SLC22A1—blood—hematologic cancer	0.000486	0.0164	CbGeAlD
Dopamine—COMT—lung—hematologic cancer	0.000484	0.0163	CbGeAlD
Dopamine—Masoprocol—ALOX5—hematologic cancer	0.000479	0.137	CrCbGaD
Dopamine—CYP1A2—hematopoietic system—hematologic cancer	0.000462	0.0156	CbGeAlD
Dopamine—COMT—testis—hematologic cancer	0.000457	0.0154	CbGeAlD
Dopamine—SLC6A2—gonad—hematologic cancer	0.000457	0.0154	CbGeAlD
Dopamine—SLC6A4—blood—hematologic cancer	0.000452	0.0152	CbGeAlD
Dopamine—HTR7—gonad—hematologic cancer	0.00044	0.0148	CbGeAlD
Dopamine—CYP2C9—hematopoietic system—hematologic cancer	0.000438	0.0148	CbGeAlD
Dopamine—SLC6A3—lung—hematologic cancer	0.000433	0.0146	CbGeAlD
Dopamine—MAOB—blood—hematologic cancer	0.00043	0.0145	CbGeAlD
Dopamine—ADRB1—lung—hematologic cancer	0.00041	0.0138	CbGeAlD
Dopamine—SLC6A3—testis—hematologic cancer	0.000408	0.0138	CbGeAlD
Dopamine—SLC22A3—lung—hematologic cancer	0.000407	0.0137	CbGeAlD
Dopamine—SLC6A4—lung—hematologic cancer	0.000396	0.0134	CbGeAlD
Dopamine—SLC22A3—testis—hematologic cancer	0.000384	0.013	CbGeAlD
Dopamine—HTR7—blood—hematologic cancer	0.000384	0.0129	CbGeAlD
Dopamine—MAOB—lung—hematologic cancer	0.000377	0.0127	CbGeAlD
Dopamine—CYP2C19—blood—hematologic cancer	0.000375	0.0126	CbGeAlD
Dopamine—MAOA—blood—hematologic cancer	0.000367	0.0124	CbGeAlD
Dopamine—MAOB—testis—hematologic cancer	0.000356	0.012	CbGeAlD
Dopamine—Mesalazine—ALOX5—hematologic cancer	0.00035	0.0996	CrCbGaD
Dopamine—SLC6A2—lung—hematologic cancer	0.000349	0.0118	CbGeAlD
Dopamine—SLC22A5—blood—hematologic cancer	0.000338	0.0114	CbGeAlD
Dopamine—HTR7—lung—hematologic cancer	0.000336	0.0113	CbGeAlD
Dopamine—COMT—lymph node—hematologic cancer	0.000331	0.0112	CbGeAlD
Dopamine—SLC6A2—testis—hematologic cancer	0.000329	0.0111	CbGeAlD
Dopamine—CYP2D6—hematopoietic system—hematologic cancer	0.000329	0.0111	CbGeAlD
Dopamine—MAOA—lung—hematologic cancer	0.000322	0.0108	CbGeAlD
Dopamine—DRD2—lung—hematologic cancer	0.000318	0.0107	CbGeAlD
Dopamine—HTR7—testis—hematologic cancer	0.000317	0.0107	CbGeAlD
Dopamine—CYP1A2—blood—hematologic cancer	0.000306	0.0103	CbGeAlD
Dopamine—MAOA—testis—hematologic cancer	0.000303	0.0102	CbGeAlD
Dopamine—DRD2—testis—hematologic cancer	0.0003	0.0101	CbGeAlD
Dopamine—SLC22A5—lung—hematologic cancer	0.000296	0.00998	CbGeAlD
Dopamine—CYP2C9—blood—hematologic cancer	0.000291	0.00979	CbGeAlD
Dopamine—SLC22A5—testis—hematologic cancer	0.000279	0.00942	CbGeAlD
Dopamine—SLC22A3—lymph node—hematologic cancer	0.000279	0.00939	CbGeAlD
Dopamine—CYP1A2—lung—hematologic cancer	0.000268	0.00904	CbGeAlD
Dopamine—MAOB—lymph node—hematologic cancer	0.000258	0.00869	CbGeAlD
Dopamine—SLC6A2—lymph node—hematologic cancer	0.000239	0.00805	CbGeAlD
Dopamine—Mesalazine—MPO—hematologic cancer	0.000225	0.0642	CrCbGaD
Dopamine—Tachycardia—Busulfan—hematologic cancer	0.000223	0.00224	CcSEcCtD
Dopamine—Vomiting—Lomustine—hematologic cancer	0.000222	0.00223	CcSEcCtD
Dopamine—Angina pectoris—Irinotecan—hematologic cancer	0.000221	0.00222	CcSEcCtD
Dopamine—MAOA—lymph node—hematologic cancer	0.00022	0.00741	CbGeAlD
Dopamine—Dyspnoea—Teniposide—hematologic cancer	0.00022	0.00221	CcSEcCtD
Dopamine—CYP2D6—blood—hematologic cancer	0.000218	0.00735	CbGeAlD
Dopamine—Palpitations—Nilotinib—hematologic cancer	0.000217	0.00218	CcSEcCtD
Dopamine—Tachycardia—Procarbazine—hematologic cancer	0.000216	0.00217	CcSEcCtD
Dopamine—Palpitations—Imatinib—hematologic cancer	0.000216	0.00217	CcSEcCtD
Dopamine—Necrosis—Epirubicin—hematologic cancer	0.000214	0.00215	CcSEcCtD
Dopamine—Vomiting—Mechlorethamine—hematologic cancer	0.000212	0.00213	CcSEcCtD
Dopamine—Hypertension—Nilotinib—hematologic cancer	0.000212	0.00213	CcSEcCtD
Dopamine—Tachycardia—Dasatinib—hematologic cancer	0.000212	0.00213	CcSEcCtD
Dopamine—Tachycardia—Bexarotene—hematologic cancer	0.000212	0.00213	CcSEcCtD
Dopamine—Hypertension—Imatinib—hematologic cancer	0.000211	0.00212	CcSEcCtD
Dopamine—Ventricular arrhythmia—Doxorubicin—hematologic cancer	0.00021	0.00211	CcSEcCtD
Dopamine—Anxiety—Nilotinib—hematologic cancer	0.000208	0.00209	CcSEcCtD
Dopamine—Anxiety—Imatinib—hematologic cancer	0.000207	0.00208	CcSEcCtD
Dopamine—Nausea—Lomustine—hematologic cancer	0.000207	0.00208	CcSEcCtD
Dopamine—Bradycardia—Thalidomide—hematologic cancer	0.000207	0.00208	CcSEcCtD
Dopamine—Extravasation—Methotrexate—hematologic cancer	0.000206	0.00207	CcSEcCtD
Dopamine—Anxiety—Cladribine—hematologic cancer	0.000204	0.00205	CcSEcCtD
Dopamine—Dyspnoea—Busulfan—hematologic cancer	0.000204	0.00204	CcSEcCtD
Dopamine—SLC22A5—lymph node—hematologic cancer	0.000203	0.00683	CbGeAlD
Dopamine—Hypertension—Vinblastine—hematologic cancer	0.000199	0.002	CcSEcCtD
Dopamine—Nausea—Mechlorethamine—hematologic cancer	0.000198	0.00199	CcSEcCtD
Dopamine—Necrosis—Doxorubicin—hematologic cancer	0.000198	0.00199	CcSEcCtD
Dopamine—Tachycardia—Nilotinib—hematologic cancer	0.000196	0.00197	CcSEcCtD
Dopamine—Tachycardia—Imatinib—hematologic cancer	0.000195	0.00195	CcSEcCtD
Dopamine—Bradycardia—Ifosfamide—hematologic cancer	0.000194	0.00195	CcSEcCtD
Dopamine—Dyspnoea—Dasatinib—hematologic cancer	0.000194	0.00194	CcSEcCtD
Dopamine—Dyspnoea—Bexarotene—hematologic cancer	0.000194	0.00194	CcSEcCtD
Dopamine—Dyspnoea—Fludarabine—hematologic cancer	0.000193	0.00194	CcSEcCtD
Dopamine—Extravasation—Epirubicin—hematologic cancer	0.000193	0.00194	CcSEcCtD
Dopamine—Tachycardia—Cladribine—hematologic cancer	0.000191	0.00192	CcSEcCtD
Dopamine—Palpitations—Lenalidomide—hematologic cancer	0.000188	0.00189	CcSEcCtD
Dopamine—Bradycardia—Mitoxantrone—hematologic cancer	0.000185	0.00185	CcSEcCtD
Dopamine—Bradycardia—Irinotecan—hematologic cancer	0.000185	0.00185	CcSEcCtD
Dopamine—Hypertension—Lenalidomide—hematologic cancer	0.000184	0.00185	CcSEcCtD
Dopamine—Anxiety—Lenalidomide—hematologic cancer	0.000181	0.00181	CcSEcCtD
Dopamine—CYP2D6—testis—hematologic cancer	0.00018	0.00608	CbGeAlD
Dopamine—Vomiting—Nelarabine—hematologic cancer	0.000179	0.0018	CcSEcCtD
Dopamine—Dyspnoea—Nilotinib—hematologic cancer	0.000179	0.0018	CcSEcCtD
Dopamine—Extravasation—Doxorubicin—hematologic cancer	0.000179	0.00179	CcSEcCtD
Dopamine—Dyspnoea—Imatinib—hematologic cancer	0.000178	0.00179	CcSEcCtD
Dopamine—Headache—Nelarabine—hematologic cancer	0.000177	0.00177	CcSEcCtD
Dopamine—Dyspnoea—Cladribine—hematologic cancer	0.000175	0.00175	CcSEcCtD
Dopamine—Tachycardia—Melphalan—hematologic cancer	0.000174	0.00175	CcSEcCtD
Dopamine—Palpitations—Bortezomib—hematologic cancer	0.000173	0.00174	CcSEcCtD
Dopamine—Headache—Methoxsalen—hematologic cancer	0.000172	0.00173	CcSEcCtD
Dopamine—Vomiting—Mercaptopurine—hematologic cancer	0.00017	0.00171	CcSEcCtD
Dopamine—Tachycardia—Lenalidomide—hematologic cancer	0.00017	0.0017	CcSEcCtD
Dopamine—Hypertension—Bortezomib—hematologic cancer	0.000169	0.0017	CcSEcCtD
Dopamine—Palpitations—Vinorelbine—hematologic cancer	0.000169	0.0017	CcSEcCtD
Dopamine—Vomiting—Daunorubicin—hematologic cancer	0.000168	0.00168	CcSEcCtD
Dopamine—Vomiting—Clofarabine—hematologic cancer	0.000168	0.00168	CcSEcCtD
Dopamine—Bradycardia—Cisplatin—hematologic cancer	0.000168	0.00168	CcSEcCtD
Dopamine—Nausea—Nelarabine—hematologic cancer	0.000167	0.00168	CcSEcCtD
Dopamine—Vomiting—Pentostatin—hematologic cancer	0.000167	0.00168	CcSEcCtD
Dopamine—Vomiting—Anagrelide—hematologic cancer	0.000167	0.00168	CcSEcCtD
Dopamine—Anxiety—Bortezomib—hematologic cancer	0.000166	0.00167	CcSEcCtD
Dopamine—Headache—Clofarabine—hematologic cancer	0.000165	0.00166	CcSEcCtD
Dopamine—Headache—Daunorubicin—hematologic cancer	0.000165	0.00166	CcSEcCtD
Dopamine—Hypertension—Vinorelbine—hematologic cancer	0.000165	0.00166	CcSEcCtD
Dopamine—Headache—Pentostatin—hematologic cancer	0.000164	0.00165	CcSEcCtD
Dopamine—Headache—Anagrelide—hematologic cancer	0.000164	0.00165	CcSEcCtD
Dopamine—Nausea—Methoxsalen—hematologic cancer	0.000164	0.00164	CcSEcCtD
Dopamine—Vomiting—Idarubicin—hematologic cancer	0.000161	0.00162	CcSEcCtD
Dopamine—Dyspnoea—Melphalan—hematologic cancer	0.000159	0.0016	CcSEcCtD
Dopamine—Nausea—Mercaptopurine—hematologic cancer	0.000159	0.0016	CcSEcCtD
Dopamine—Headache—Idarubicin—hematologic cancer	0.000159	0.00159	CcSEcCtD
Dopamine—Hypertension—Thiotepa—hematologic cancer	0.000158	0.00158	CcSEcCtD
Dopamine—Norepinephrine—SLC22A1—hematologic cancer	0.000157	0.0447	CrCbGaD
Dopamine—Nausea—Clofarabine—hematologic cancer	0.000157	0.00157	CcSEcCtD
Dopamine—Nausea—Daunorubicin—hematologic cancer	0.000157	0.00157	CcSEcCtD
Dopamine—Vomiting—Teniposide—hematologic cancer	0.000157	0.00157	CcSEcCtD
Dopamine—Palpitations—Thalidomide—hematologic cancer	0.000156	0.00157	CcSEcCtD
Dopamine—Tachycardia—Bortezomib—hematologic cancer	0.000156	0.00157	CcSEcCtD
Dopamine—Nausea—Pentostatin—hematologic cancer	0.000156	0.00157	CcSEcCtD
Dopamine—Nausea—Anagrelide—hematologic cancer	0.000156	0.00157	CcSEcCtD
Dopamine—Anxiety—Thiotepa—hematologic cancer	0.000155	0.00156	CcSEcCtD
Dopamine—Dyspnoea—Lenalidomide—hematologic cancer	0.000155	0.00156	CcSEcCtD
Dopamine—Headache—Teniposide—hematologic cancer	0.000154	0.00155	CcSEcCtD
Dopamine—Dyspnoea—Hydroxyurea—hematologic cancer	0.000153	0.00153	CcSEcCtD
Dopamine—Hypertension—Thalidomide—hematologic cancer	0.000153	0.00153	CcSEcCtD
Dopamine—Tachycardia—Vinorelbine—hematologic cancer	0.000152	0.00153	CcSEcCtD
Dopamine—Bradycardia—Prednisolone—hematologic cancer	0.000151	0.00152	CcSEcCtD
Dopamine—Nausea—Idarubicin—hematologic cancer	0.00015	0.00151	CcSEcCtD
Dopamine—Anxiety—Thalidomide—hematologic cancer	0.00015	0.00151	CcSEcCtD
Dopamine—Palpitations—Alitretinoin—hematologic cancer	0.000149	0.00149	CcSEcCtD
Dopamine—Palpitations—Ifosfamide—hematologic cancer	0.000147	0.00148	CcSEcCtD
Dopamine—Hypertension—Carmustine—hematologic cancer	0.000147	0.00147	CcSEcCtD
Dopamine—Nausea—Teniposide—hematologic cancer	0.000146	0.00147	CcSEcCtD
Dopamine—Tachycardia—Thiotepa—hematologic cancer	0.000146	0.00146	CcSEcCtD
Dopamine—Hypertension—Alitretinoin—hematologic cancer	0.000145	0.00146	CcSEcCtD
Dopamine—Vomiting—Busulfan—hematologic cancer	0.000145	0.00146	CcSEcCtD
Dopamine—Anxiety—Carmustine—hematologic cancer	0.000144	0.00145	CcSEcCtD
Dopamine—Hypertension—Ifosfamide—hematologic cancer	0.000144	0.00144	CcSEcCtD
Dopamine—Headache—Busulfan—hematologic cancer	0.000143	0.00144	CcSEcCtD
Dopamine—Anxiety—Alitretinoin—hematologic cancer	0.000143	0.00143	CcSEcCtD
Dopamine—Dyspnoea—Bortezomib—hematologic cancer	0.000143	0.00143	CcSEcCtD
Dopamine—Epinephrine—SLC22A1—hematologic cancer	0.000142	0.0405	CrCbGaD
Dopamine—Dyspnoea—Bleomycin—hematologic cancer	0.000142	0.00142	CcSEcCtD
Dopamine—Vomiting—Procarbazine—hematologic cancer	0.000141	0.00141	CcSEcCtD
Dopamine—Tachycardia—Thalidomide—hematologic cancer	0.000141	0.00141	CcSEcCtD
Dopamine—Hypertension—Vincristine—hematologic cancer	0.00014	0.00141	CcSEcCtD
Dopamine—Bradycardia—Triamcinolone—hematologic cancer	0.000139	0.0014	CcSEcCtD
Dopamine—Dyspnoea—Vinorelbine—hematologic cancer	0.000139	0.0014	CcSEcCtD
Dopamine—Headache—Procarbazine—hematologic cancer	0.000139	0.00139	CcSEcCtD
Dopamine—Vomiting—Bexarotene—hematologic cancer	0.000138	0.00139	CcSEcCtD
Dopamine—Vomiting—Dasatinib—hematologic cancer	0.000138	0.00139	CcSEcCtD
Dopamine—Vomiting—Fludarabine—hematologic cancer	0.000138	0.00138	CcSEcCtD
Dopamine—Hypertension—Mitoxantrone—hematologic cancer	0.000136	0.00137	CcSEcCtD
Dopamine—Hypertension—Irinotecan—hematologic cancer	0.000136	0.00137	CcSEcCtD
Dopamine—Headache—Dasatinib—hematologic cancer	0.000136	0.00137	CcSEcCtD
Dopamine—Headache—Bexarotene—hematologic cancer	0.000136	0.00137	CcSEcCtD
Dopamine—Headache—Fludarabine—hematologic cancer	0.000136	0.00136	CcSEcCtD
Dopamine—Nausea—Busulfan—hematologic cancer	0.000136	0.00136	CcSEcCtD
Dopamine—Tachycardia—Carmustine—hematologic cancer	0.000135	0.00136	CcSEcCtD
Dopamine—Tachycardia—Alitretinoin—hematologic cancer	0.000134	0.00135	CcSEcCtD
Dopamine—Anxiety—Mitoxantrone—hematologic cancer	0.000134	0.00134	CcSEcCtD
Dopamine—Hypertension—Gemcitabine—hematologic cancer	0.000133	0.00133	CcSEcCtD
Dopamine—Nausea—Procarbazine—hematologic cancer	0.000132	0.00132	CcSEcCtD
Dopamine—Vomiting—Chlorambucil—hematologic cancer	0.00013	0.00131	CcSEcCtD
Dopamine—Nausea—Bexarotene—hematologic cancer	0.000129	0.00129	CcSEcCtD
Dopamine—Nausea—Dasatinib—hematologic cancer	0.000129	0.00129	CcSEcCtD
Dopamine—Dyspnoea—Thalidomide—hematologic cancer	0.000129	0.00129	CcSEcCtD
Dopamine—Nausea—Fludarabine—hematologic cancer	0.000129	0.00129	CcSEcCtD
Dopamine—Vomiting—Nilotinib—hematologic cancer	0.000128	0.00128	CcSEcCtD
Dopamine—Vomiting—Imatinib—hematologic cancer	0.000127	0.00127	CcSEcCtD
Dopamine—Bradycardia—Betamethasone—hematologic cancer	0.000126	0.00127	CcSEcCtD
Dopamine—Bradycardia—Dexamethasone—hematologic cancer	0.000126	0.00127	CcSEcCtD
Dopamine—Tachycardia—Mitoxantrone—hematologic cancer	0.000126	0.00126	CcSEcCtD
Dopamine—Headache—Nilotinib—hematologic cancer	0.000126	0.00126	CcSEcCtD
Dopamine—Headache—Imatinib—hematologic cancer	0.000125	0.00125	CcSEcCtD
Dopamine—Vomiting—Cladribine—hematologic cancer	0.000125	0.00125	CcSEcCtD
Dopamine—Dyspnoea—Carmustine—hematologic cancer	0.000124	0.00124	CcSEcCtD
Dopamine—Headache—Cladribine—hematologic cancer	0.000123	0.00123	CcSEcCtD
Dopamine—Dyspnoea—Alitretinoin—hematologic cancer	0.000122	0.00123	CcSEcCtD
Dopamine—Nausea—Chlorambucil—hematologic cancer	0.000122	0.00122	CcSEcCtD
Dopamine—Anxiety—Cisplatin—hematologic cancer	0.000122	0.00122	CcSEcCtD
Dopamine—Dyspnoea—Ifosfamide—hematologic cancer	0.000121	0.00121	CcSEcCtD
Dopamine—Vomiting—Vinblastine—hematologic cancer	0.000119	0.0012	CcSEcCtD
Dopamine—Nausea—Nilotinib—hematologic cancer	0.000119	0.0012	CcSEcCtD
Dopamine—Nausea—Imatinib—hematologic cancer	0.000118	0.00119	CcSEcCtD
Dopamine—Headache—Vinblastine—hematologic cancer	0.000118	0.00118	CcSEcCtD
Dopamine—Nausea—Cladribine—hematologic cancer	0.000116	0.00117	CcSEcCtD
Dopamine—Dyspnoea—Mitoxantrone—hematologic cancer	0.000115	0.00115	CcSEcCtD
Dopamine—Dyspnoea—Irinotecan—hematologic cancer	0.000115	0.00115	CcSEcCtD
Dopamine—Tachycardia—Cisplatin—hematologic cancer	0.000114	0.00115	CcSEcCtD
Dopamine—Vomiting—Melphalan—hematologic cancer	0.000114	0.00114	CcSEcCtD
Dopamine—Hypertension—Etoposide—hematologic cancer	0.000113	0.00114	CcSEcCtD
Dopamine—Dyspnoea—Gemcitabine—hematologic cancer	0.000112	0.00112	CcSEcCtD
Dopamine—Hypertension—Prednisolone—hematologic cancer	0.000112	0.00112	CcSEcCtD
Dopamine—Nausea—Vinblastine—hematologic cancer	0.000112	0.00112	CcSEcCtD
Dopamine—Vomiting—Lenalidomide—hematologic cancer	0.000111	0.00111	CcSEcCtD
Dopamine—Bradycardia—Prednisone—hematologic cancer	0.00011	0.0011	CcSEcCtD
Dopamine—Vomiting—Hydroxyurea—hematologic cancer	0.000109	0.00109	CcSEcCtD
Dopamine—Headache—Lenalidomide—hematologic cancer	0.000109	0.00109	CcSEcCtD
Dopamine—Headache—Hydroxyurea—hematologic cancer	0.000107	0.00108	CcSEcCtD
Dopamine—Nausea—Melphalan—hematologic cancer	0.000106	0.00107	CcSEcCtD
Dopamine—Tachycardia—Etoposide—hematologic cancer	0.000105	0.00105	CcSEcCtD
Dopamine—Dyspnoea—Cisplatin—hematologic cancer	0.000104	0.00105	CcSEcCtD
Dopamine—Nausea—Lenalidomide—hematologic cancer	0.000103	0.00104	CcSEcCtD
Dopamine—Tachycardia—Prednisolone—hematologic cancer	0.000103	0.00104	CcSEcCtD
Dopamine—Angina pectoris—Epirubicin—hematologic cancer	0.000103	0.00103	CcSEcCtD
Dopamine—Hypertension—Triamcinolone—hematologic cancer	0.000103	0.00103	CcSEcCtD
Dopamine—Epinephrine—TNF—hematologic cancer	0.000102	0.0292	CrCbGaD
Dopamine—Nausea—Hydroxyurea—hematologic cancer	0.000102	0.00102	CcSEcCtD
Dopamine—Vomiting—Bortezomib—hematologic cancer	0.000102	0.00102	CcSEcCtD
Dopamine—Vomiting—Bleomycin—hematologic cancer	0.000101	0.00101	CcSEcCtD
Dopamine—Headache—Bortezomib—hematologic cancer	0.0001	0.00101	CcSEcCtD
Dopamine—Vomiting—Vinorelbine—hematologic cancer	9.93e-05	0.000997	CcSEcCtD
Dopamine—Headache—Vinorelbine—hematologic cancer	9.78e-05	0.000983	CcSEcCtD
Dopamine—Dyspnoea—Etoposide—hematologic cancer	9.55e-05	0.000959	CcSEcCtD
Dopamine—Angina pectoris—Doxorubicin—hematologic cancer	9.52e-05	0.000956	CcSEcCtD
Dopamine—Nausea—Bortezomib—hematologic cancer	9.5e-05	0.000954	CcSEcCtD
Dopamine—Tachycardia—Triamcinolone—hematologic cancer	9.48e-05	0.000952	CcSEcCtD
Dopamine—Vomiting—Thiotepa—hematologic cancer	9.48e-05	0.000952	CcSEcCtD
Dopamine—Nausea—Bleomycin—hematologic cancer	9.43e-05	0.000947	CcSEcCtD
Dopamine—Headache—Thiotepa—hematologic cancer	9.34e-05	0.000938	CcSEcCtD
Dopamine—Hypertension—Betamethasone—hematologic cancer	9.33e-05	0.000937	CcSEcCtD
Dopamine—Hypertension—Dexamethasone—hematologic cancer	9.33e-05	0.000937	CcSEcCtD
Dopamine—Nausea—Vinorelbine—hematologic cancer	9.28e-05	0.000932	CcSEcCtD
Dopamine—Vomiting—Thalidomide—hematologic cancer	9.17e-05	0.000921	CcSEcCtD
Dopamine—Anxiety—Dexamethasone—hematologic cancer	9.17e-05	0.00092	CcSEcCtD
Dopamine—Anxiety—Betamethasone—hematologic cancer	9.17e-05	0.00092	CcSEcCtD
Dopamine—Headache—Thalidomide—hematologic cancer	9.04e-05	0.000908	CcSEcCtD
Dopamine—Nausea—Thiotepa—hematologic cancer	8.86e-05	0.00089	CcSEcCtD
Dopamine—Vomiting—Carmustine—hematologic cancer	8.81e-05	0.000885	CcSEcCtD
Dopamine—Vomiting—Alitretinoin—hematologic cancer	8.73e-05	0.000876	CcSEcCtD
Dopamine—Headache—Carmustine—hematologic cancer	8.68e-05	0.000872	CcSEcCtD
Dopamine—Dyspnoea—Triamcinolone—hematologic cancer	8.66e-05	0.00087	CcSEcCtD
Dopamine—Vomiting—Ifosfamide—hematologic cancer	8.62e-05	0.000866	CcSEcCtD
Dopamine—Tachycardia—Dexamethasone—hematologic cancer	8.61e-05	0.000864	CcSEcCtD
Dopamine—Tachycardia—Betamethasone—hematologic cancer	8.61e-05	0.000864	CcSEcCtD
Dopamine—Bradycardia—Epirubicin—hematologic cancer	8.61e-05	0.000864	CcSEcCtD
Dopamine—Headache—Alitretinoin—hematologic cancer	8.6e-05	0.000863	CcSEcCtD
Dopamine—Nausea—Thalidomide—hematologic cancer	8.57e-05	0.000861	CcSEcCtD
Dopamine—Vomiting—Vincristine—hematologic cancer	8.41e-05	0.000844	CcSEcCtD
Dopamine—Headache—Vincristine—hematologic cancer	8.29e-05	0.000832	CcSEcCtD
Dopamine—Nausea—Carmustine—hematologic cancer	8.23e-05	0.000826	CcSEcCtD
Dopamine—Vomiting—Mitoxantrone—hematologic cancer	8.19e-05	0.000822	CcSEcCtD
Dopamine—Vomiting—Irinotecan—hematologic cancer	8.19e-05	0.000822	CcSEcCtD
Dopamine—Nausea—Alitretinoin—hematologic cancer	8.15e-05	0.000819	CcSEcCtD
Dopamine—Hypertension—Prednisone—hematologic cancer	8.12e-05	0.000816	CcSEcCtD
Dopamine—Headache—Mitoxantrone—hematologic cancer	8.07e-05	0.00081	CcSEcCtD
Dopamine—Headache—Irinotecan—hematologic cancer	8.07e-05	0.00081	CcSEcCtD
Dopamine—Nausea—Ifosfamide—hematologic cancer	8.06e-05	0.000809	CcSEcCtD
Dopamine—Anxiety—Prednisone—hematologic cancer	7.98e-05	0.000802	CcSEcCtD
Dopamine—Vomiting—Gemcitabine—hematologic cancer	7.98e-05	0.000801	CcSEcCtD
Dopamine—Bradycardia—Doxorubicin—hematologic cancer	7.96e-05	0.0008	CcSEcCtD
Dopamine—Headache—Gemcitabine—hematologic cancer	7.86e-05	0.000789	CcSEcCtD
Dopamine—Nausea—Vincristine—hematologic cancer	7.86e-05	0.000789	CcSEcCtD
Dopamine—Nausea—Irinotecan—hematologic cancer	7.65e-05	0.000768	CcSEcCtD
Dopamine—Nausea—Mitoxantrone—hematologic cancer	7.65e-05	0.000768	CcSEcCtD
Dopamine—Tachycardia—Prednisone—hematologic cancer	7.49e-05	0.000753	CcSEcCtD
Dopamine—Nausea—Gemcitabine—hematologic cancer	7.45e-05	0.000748	CcSEcCtD
Dopamine—Vomiting—Cisplatin—hematologic cancer	7.44e-05	0.000747	CcSEcCtD
Dopamine—Nausea—Cisplatin—hematologic cancer	6.95e-05	0.000698	CcSEcCtD
Dopamine—Vomiting—Etoposide—hematologic cancer	6.81e-05	0.000684	CcSEcCtD
Dopamine—Headache—Etoposide—hematologic cancer	6.71e-05	0.000674	CcSEcCtD
Dopamine—Headache—Prednisolone—hematologic cancer	6.62e-05	0.000665	CcSEcCtD
Dopamine—Palpitations—Epirubicin—hematologic cancer	6.5e-05	0.000653	CcSEcCtD
Dopamine—Nausea—Etoposide—hematologic cancer	6.36e-05	0.000639	CcSEcCtD
Dopamine—Hypertension—Epirubicin—hematologic cancer	6.35e-05	0.000638	CcSEcCtD
Dopamine—Nausea—Prednisolone—hematologic cancer	6.28e-05	0.00063	CcSEcCtD
Dopamine—Anxiety—Epirubicin—hematologic cancer	6.24e-05	0.000627	CcSEcCtD
Dopamine—Vomiting—Triamcinolone—hematologic cancer	6.18e-05	0.00062	CcSEcCtD
Dopamine—Headache—Triamcinolone—hematologic cancer	6.09e-05	0.000611	CcSEcCtD
Dopamine—Palpitations—Doxorubicin—hematologic cancer	6.02e-05	0.000604	CcSEcCtD
Dopamine—Hypertension—Doxorubicin—hematologic cancer	5.88e-05	0.00059	CcSEcCtD
Dopamine—Tachycardia—Epirubicin—hematologic cancer	5.86e-05	0.000589	CcSEcCtD
Dopamine—Anxiety—Doxorubicin—hematologic cancer	5.78e-05	0.00058	CcSEcCtD
Dopamine—Nausea—Triamcinolone—hematologic cancer	5.77e-05	0.00058	CcSEcCtD
Dopamine—Dyspnoea—Methotrexate—hematologic cancer	5.72e-05	0.000575	CcSEcCtD
Dopamine—Vomiting—Dexamethasone—hematologic cancer	5.61e-05	0.000563	CcSEcCtD
Dopamine—Vomiting—Betamethasone—hematologic cancer	5.61e-05	0.000563	CcSEcCtD
Dopamine—Headache—Dexamethasone—hematologic cancer	5.52e-05	0.000555	CcSEcCtD
Dopamine—Headache—Betamethasone—hematologic cancer	5.52e-05	0.000555	CcSEcCtD
Dopamine—Tachycardia—Doxorubicin—hematologic cancer	5.42e-05	0.000545	CcSEcCtD
Dopamine—Dyspnoea—Epirubicin—hematologic cancer	5.35e-05	0.000538	CcSEcCtD
Dopamine—Nausea—Dexamethasone—hematologic cancer	5.24e-05	0.000526	CcSEcCtD
Dopamine—Nausea—Betamethasone—hematologic cancer	5.24e-05	0.000526	CcSEcCtD
Dopamine—Dyspnoea—Doxorubicin—hematologic cancer	4.95e-05	0.000498	CcSEcCtD
Dopamine—Vomiting—Prednisone—hematologic cancer	4.88e-05	0.00049	CcSEcCtD
Dopamine—Headache—Prednisone—hematologic cancer	4.81e-05	0.000483	CcSEcCtD
Dopamine—Nausea—Prednisone—hematologic cancer	4.56e-05	0.000458	CcSEcCtD
Dopamine—Vomiting—Methotrexate—hematologic cancer	4.08e-05	0.00041	CcSEcCtD
Dopamine—Headache—Methotrexate—hematologic cancer	4.02e-05	0.000404	CcSEcCtD
Dopamine—Vomiting—Epirubicin—hematologic cancer	3.82e-05	0.000383	CcSEcCtD
Dopamine—Nausea—Methotrexate—hematologic cancer	3.81e-05	0.000383	CcSEcCtD
Dopamine—Headache—Epirubicin—hematologic cancer	3.76e-05	0.000378	CcSEcCtD
Dopamine—Nausea—Epirubicin—hematologic cancer	3.57e-05	0.000358	CcSEcCtD
Dopamine—Vomiting—Doxorubicin—hematologic cancer	3.53e-05	0.000355	CcSEcCtD
Dopamine—Headache—Doxorubicin—hematologic cancer	3.48e-05	0.00035	CcSEcCtD
Dopamine—Nausea—Doxorubicin—hematologic cancer	3.3e-05	0.000331	CcSEcCtD
Dopamine—DRD1—GPCR downstream signaling—AKT1—hematologic cancer	1.48e-06	1.52e-05	CbGpPWpGaD
Dopamine—ADRB1—Signaling by GPCR—PIK3CA—hematologic cancer	1.48e-06	1.52e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—BRAF—hematologic cancer	1.48e-06	1.52e-05	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—CDKN1B—hematologic cancer	1.48e-06	1.52e-05	CbGpPWpGaD
Dopamine—CYP2D6—Metabolism—GSTM1—hematologic cancer	1.48e-06	1.52e-05	CbGpPWpGaD
Dopamine—CYP2D6—Metabolism—NCOR1—hematologic cancer	1.48e-06	1.52e-05	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—MDM2—hematologic cancer	1.47e-06	1.52e-05	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—CASP3—hematologic cancer	1.47e-06	1.51e-05	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—IL2—hematologic cancer	1.47e-06	1.51e-05	CbGpPWpGaD
Dopamine—CYP2C9—Metabolism—GSTM1—hematologic cancer	1.46e-06	1.51e-05	CbGpPWpGaD
Dopamine—CYP2C9—Metabolism—NCOR1—hematologic cancer	1.46e-06	1.51e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—CCL2—hematologic cancer	1.46e-06	1.51e-05	CbGpPWpGaD
Dopamine—DRD5—Signaling Pathways—PIK3CA—hematologic cancer	1.46e-06	1.51e-05	CbGpPWpGaD
Dopamine—DRD3—GPCR downstream signaling—AKT1—hematologic cancer	1.46e-06	1.5e-05	CbGpPWpGaD
Dopamine—DRD4—Signaling Pathways—EP300—hematologic cancer	1.46e-06	1.5e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—IL6R—hematologic cancer	1.46e-06	1.5e-05	CbGpPWpGaD
Dopamine—DRD1—Signaling by GPCR—IL6—hematologic cancer	1.46e-06	1.5e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—CREBBP—hematologic cancer	1.46e-06	1.5e-05	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—CASP3—hematologic cancer	1.45e-06	1.49e-05	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—IL2—hematologic cancer	1.45e-06	1.49e-05	CbGpPWpGaD
Dopamine—HTR7—Signaling Pathways—VEGFA—hematologic cancer	1.45e-06	1.49e-05	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—JAK2—hematologic cancer	1.44e-06	1.49e-05	CbGpPWpGaD
Dopamine—DRD3—Signaling by GPCR—IL6—hematologic cancer	1.44e-06	1.48e-05	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—MTOR—hematologic cancer	1.43e-06	1.48e-05	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—PIK3CB—hematologic cancer	1.43e-06	1.48e-05	CbGpPWpGaD
Dopamine—HTR7—Signaling Pathways—STAT3—hematologic cancer	1.43e-06	1.47e-05	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—CCND1—hematologic cancer	1.43e-06	1.47e-05	CbGpPWpGaD
Dopamine—HTR7—Signaling Pathways—NRAS—hematologic cancer	1.43e-06	1.47e-05	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—JUN—hematologic cancer	1.43e-06	1.47e-05	CbGpPWpGaD
Dopamine—DRD4—Signaling Pathways—SRC—hematologic cancer	1.42e-06	1.46e-05	CbGpPWpGaD
Dopamine—CYP2C19—Metabolism—MTHFR—hematologic cancer	1.42e-06	1.46e-05	CbGpPWpGaD
Dopamine—DRD5—Signaling Pathways—TP53—hematologic cancer	1.42e-06	1.46e-05	CbGpPWpGaD
Dopamine—HTR1A—Signaling by GPCR—PIK3CA—hematologic cancer	1.42e-06	1.46e-05	CbGpPWpGaD
Dopamine—SLC22A2—Metabolism—PTEN—hematologic cancer	1.41e-06	1.45e-05	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—MDM2—hematologic cancer	1.41e-06	1.45e-05	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—CCND1—hematologic cancer	1.41e-06	1.45e-05	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—JUN—hematologic cancer	1.41e-06	1.45e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—MAP2K1—hematologic cancer	1.39e-06	1.43e-05	CbGpPWpGaD
Dopamine—DRD4—Signaling Pathways—VEGFA—hematologic cancer	1.38e-06	1.42e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—PIK3CD—hematologic cancer	1.38e-06	1.42e-05	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—CDKN1A—hematologic cancer	1.38e-06	1.42e-05	CbGpPWpGaD
Dopamine—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	1.38e-06	1.42e-05	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—PTEN—hematologic cancer	1.38e-06	1.42e-05	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—MTOR—hematologic cancer	1.37e-06	1.41e-05	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—PIK3CB—hematologic cancer	1.37e-06	1.41e-05	CbGpPWpGaD
Dopamine—DRD4—Signaling Pathways—STAT3—hematologic cancer	1.37e-06	1.41e-05	CbGpPWpGaD
Dopamine—ADRB1—Signaling by GPCR—HRAS—hematologic cancer	1.37e-06	1.41e-05	CbGpPWpGaD
Dopamine—DRD2—GPCR downstream signaling—PIK3CA—hematologic cancer	1.37e-06	1.41e-05	CbGpPWpGaD
Dopamine—HTR7—Signaling Pathways—MAPK3—hematologic cancer	1.37e-06	1.41e-05	CbGpPWpGaD
Dopamine—DRD4—Signaling Pathways—NRAS—hematologic cancer	1.37e-06	1.41e-05	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—CDKN1A—hematologic cancer	1.36e-06	1.4e-05	CbGpPWpGaD
Dopamine—CYP1A2—Metabolism—GSTP1—hematologic cancer	1.36e-06	1.4e-05	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—PTEN—hematologic cancer	1.36e-06	1.4e-05	CbGpPWpGaD
Dopamine—DRD5—Signaling Pathways—HRAS—hematologic cancer	1.35e-06	1.39e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling by GPCR—KRAS—hematologic cancer	1.35e-06	1.39e-05	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—MAPK8—hematologic cancer	1.35e-06	1.39e-05	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—CDKN1B—hematologic cancer	1.35e-06	1.39e-05	CbGpPWpGaD
Dopamine—SLC22A2—Metabolism—EP300—hematologic cancer	1.35e-06	1.38e-05	CbGpPWpGaD
Dopamine—DRD1—Signaling by GPCR—AKT1—hematologic cancer	1.35e-06	1.38e-05	CbGpPWpGaD
Dopamine—ADRB1—GPCR downstream signaling—AKT1—hematologic cancer	1.33e-06	1.37e-05	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—MAPK8—hematologic cancer	1.33e-06	1.37e-05	CbGpPWpGaD
Dopamine—HTR7—Signaling Pathways—MYC—hematologic cancer	1.33e-06	1.37e-05	CbGpPWpGaD
Dopamine—DRD3—Signaling by GPCR—AKT1—hematologic cancer	1.33e-06	1.37e-05	CbGpPWpGaD
Dopamine—HTR7—Signaling Pathways—TGFB1—hematologic cancer	1.33e-06	1.36e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—FGF2—hematologic cancer	1.32e-06	1.36e-05	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—CASP3—hematologic cancer	1.32e-06	1.36e-05	CbGpPWpGaD
Dopamine—CYP1A2—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	1.32e-06	1.36e-05	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—IL2—hematologic cancer	1.32e-06	1.36e-05	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—EP300—hematologic cancer	1.31e-06	1.35e-05	CbGpPWpGaD
Dopamine—SLC22A1—Metabolism—PTEN—hematologic cancer	1.31e-06	1.35e-05	CbGpPWpGaD
Dopamine—ADRB1—Signaling by GPCR—IL6—hematologic cancer	1.31e-06	1.35e-05	CbGpPWpGaD
Dopamine—HTR1A—Signaling by GPCR—HRAS—hematologic cancer	1.31e-06	1.35e-05	CbGpPWpGaD
Dopamine—DRD4—Signaling Pathways—MAPK3—hematologic cancer	1.31e-06	1.35e-05	CbGpPWpGaD
Dopamine—CYP2D6—Metabolism—MTHFR—hematologic cancer	1.31e-06	1.34e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—PIK3R1—hematologic cancer	1.31e-06	1.34e-05	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—EP300—hematologic cancer	1.3e-06	1.33e-05	CbGpPWpGaD
Dopamine—DRD5—Signaling Pathways—IL6—hematologic cancer	1.3e-06	1.33e-05	CbGpPWpGaD
Dopamine—SLC22A3—Metabolism—AKT1—hematologic cancer	1.3e-06	1.33e-05	CbGpPWpGaD
Dopamine—CYP2C9—Metabolism—MTHFR—hematologic cancer	1.29e-06	1.33e-05	CbGpPWpGaD
Dopamine—CYP1A2—Metabolism—ABCB1—hematologic cancer	1.29e-06	1.33e-05	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—CDKN1B—hematologic cancer	1.29e-06	1.32e-05	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—CCND1—hematologic cancer	1.28e-06	1.32e-05	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—JUN—hematologic cancer	1.28e-06	1.32e-05	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—SRC—hematologic cancer	1.28e-06	1.32e-05	CbGpPWpGaD
Dopamine—HTR1A—GPCR downstream signaling—AKT1—hematologic cancer	1.27e-06	1.31e-05	CbGpPWpGaD
Dopamine—DRD4—Signaling Pathways—MYC—hematologic cancer	1.27e-06	1.31e-05	CbGpPWpGaD
Dopamine—DRD4—Signaling Pathways—TGFB1—hematologic cancer	1.27e-06	1.31e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—JAK2—hematologic cancer	1.27e-06	1.31e-05	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—CASP3—hematologic cancer	1.26e-06	1.3e-05	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—SRC—hematologic cancer	1.26e-06	1.3e-05	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—IL2—hematologic cancer	1.26e-06	1.3e-05	CbGpPWpGaD
Dopamine—SLC22A1—Metabolism—EP300—hematologic cancer	1.25e-06	1.29e-05	CbGpPWpGaD
Dopamine—HTR1A—Signaling by GPCR—IL6—hematologic cancer	1.25e-06	1.29e-05	CbGpPWpGaD
Dopamine—CYP1A2—Metabolism—NCOR1—hematologic cancer	1.25e-06	1.29e-05	CbGpPWpGaD
Dopamine—CYP1A2—Metabolism—GSTM1—hematologic cancer	1.25e-06	1.29e-05	CbGpPWpGaD
Dopamine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	1.25e-06	1.29e-05	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—VEGFA—hematologic cancer	1.25e-06	1.28e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling by GPCR—PIK3CA—hematologic cancer	1.24e-06	1.28e-05	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—CDKN1A—hematologic cancer	1.24e-06	1.28e-05	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—PTEN—hematologic cancer	1.24e-06	1.28e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—MDM2—hematologic cancer	1.24e-06	1.27e-05	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—STAT3—hematologic cancer	1.23e-06	1.27e-05	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—NRAS—hematologic cancer	1.23e-06	1.27e-05	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—VEGFA—hematologic cancer	1.23e-06	1.26e-05	CbGpPWpGaD
Dopamine—HTR7—Signaling Pathways—KRAS—hematologic cancer	1.23e-06	1.26e-05	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—CCND1—hematologic cancer	1.23e-06	1.26e-05	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—JUN—hematologic cancer	1.23e-06	1.26e-05	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—STAT3—hematologic cancer	1.22e-06	1.25e-05	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—NRAS—hematologic cancer	1.21e-06	1.25e-05	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—MAPK8—hematologic cancer	1.21e-06	1.25e-05	CbGpPWpGaD
Dopamine—ADRB1—Signaling by GPCR—AKT1—hematologic cancer	1.21e-06	1.24e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—PIK3CB—hematologic cancer	1.2e-06	1.24e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—MTOR—hematologic cancer	1.2e-06	1.24e-05	CbGpPWpGaD
Dopamine—DRD5—Signaling Pathways—AKT1—hematologic cancer	1.2e-06	1.23e-05	CbGpPWpGaD
Dopamine—CYP2C19—Metabolism—PIK3CG—hematologic cancer	1.19e-06	1.23e-05	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—CDKN1A—hematologic cancer	1.19e-06	1.22e-05	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—PTEN—hematologic cancer	1.19e-06	1.22e-05	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—EP300—hematologic cancer	1.18e-06	1.22e-05	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—MAPK3—hematologic cancer	1.18e-06	1.21e-05	CbGpPWpGaD
Dopamine—MAOA—Metabolism—PIK3CA—hematologic cancer	1.18e-06	1.21e-05	CbGpPWpGaD
Dopamine—DRD4—Signaling Pathways—KRAS—hematologic cancer	1.18e-06	1.21e-05	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—MAPK3—hematologic cancer	1.16e-06	1.2e-05	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—MAPK8—hematologic cancer	1.16e-06	1.19e-05	CbGpPWpGaD
Dopamine—HTR1A—Signaling by GPCR—AKT1—hematologic cancer	1.16e-06	1.19e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling by GPCR—HRAS—hematologic cancer	1.15e-06	1.18e-05	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—SRC—hematologic cancer	1.15e-06	1.18e-05	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—MYC—hematologic cancer	1.15e-06	1.18e-05	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—TGFB1—hematologic cancer	1.14e-06	1.18e-05	CbGpPWpGaD
Dopamine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	1.14e-06	1.17e-05	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—EP300—hematologic cancer	1.13e-06	1.16e-05	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—MYC—hematologic cancer	1.13e-06	1.16e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—CDKN1B—hematologic cancer	1.13e-06	1.16e-05	CbGpPWpGaD
Dopamine—HTR7—Signaling Pathways—PIK3CA—hematologic cancer	1.13e-06	1.16e-05	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—TGFB1—hematologic cancer	1.13e-06	1.16e-05	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—VEGFA—hematologic cancer	1.12e-06	1.15e-05	CbGpPWpGaD
Dopamine—DRD2—GPCR downstream signaling—AKT1—hematologic cancer	1.12e-06	1.15e-05	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—STAT3—hematologic cancer	1.11e-06	1.14e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—CASP3—hematologic cancer	1.11e-06	1.14e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—IL2—hematologic cancer	1.11e-06	1.14e-05	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—NRAS—hematologic cancer	1.11e-06	1.14e-05	CbGpPWpGaD
Dopamine—CYP1A2—Metabolism—MTHFR—hematologic cancer	1.11e-06	1.14e-05	CbGpPWpGaD
Dopamine—CYP2C19—Metabolism—CREBBP—hematologic cancer	1.11e-06	1.14e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling by GPCR—IL6—hematologic cancer	1.1e-06	1.13e-05	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—SRC—hematologic cancer	1.1e-06	1.13e-05	CbGpPWpGaD
Dopamine—CYP2D6—Metabolism—PIK3CG—hematologic cancer	1.1e-06	1.13e-05	CbGpPWpGaD
Dopamine—HTR7—Signaling Pathways—TP53—hematologic cancer	1.09e-06	1.12e-05	CbGpPWpGaD
Dopamine—CYP2C9—Metabolism—PIK3CG—hematologic cancer	1.09e-06	1.12e-05	CbGpPWpGaD
Dopamine—DRD4—Signaling Pathways—PIK3CA—hematologic cancer	1.08e-06	1.11e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—CCND1—hematologic cancer	1.08e-06	1.11e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—JUN—hematologic cancer	1.08e-06	1.11e-05	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—VEGFA—hematologic cancer	1.07e-06	1.1e-05	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—STAT3—hematologic cancer	1.06e-06	1.09e-05	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—MAPK3—hematologic cancer	1.06e-06	1.09e-05	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—KRAS—hematologic cancer	1.06e-06	1.09e-05	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—NRAS—hematologic cancer	1.06e-06	1.09e-05	CbGpPWpGaD
Dopamine—CYP2C19—Metabolism—PIK3CD—hematologic cancer	1.05e-06	1.08e-05	CbGpPWpGaD
Dopamine—DRD4—Signaling Pathways—TP53—hematologic cancer	1.05e-06	1.08e-05	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—KRAS—hematologic cancer	1.04e-06	1.07e-05	CbGpPWpGaD
Dopamine—HTR7—Signaling Pathways—HRAS—hematologic cancer	1.04e-06	1.07e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—CDKN1A—hematologic cancer	1.04e-06	1.07e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—PTEN—hematologic cancer	1.04e-06	1.07e-05	CbGpPWpGaD
Dopamine—CYP2C19—Metabolism—ALB—hematologic cancer	1.03e-06	1.06e-05	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—MYC—hematologic cancer	1.03e-06	1.06e-05	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—TGFB1—hematologic cancer	1.03e-06	1.06e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—MAPK8—hematologic cancer	1.02e-06	1.05e-05	CbGpPWpGaD
Dopamine—CYP2D6—Metabolism—CREBBP—hematologic cancer	1.02e-06	1.05e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling by GPCR—AKT1—hematologic cancer	1.02e-06	1.04e-05	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—MAPK3—hematologic cancer	1.01e-06	1.04e-05	CbGpPWpGaD
Dopamine—CYP2C9—Metabolism—CREBBP—hematologic cancer	1.01e-06	1.04e-05	CbGpPWpGaD
Dopamine—DRD4—Signaling Pathways—HRAS—hematologic cancer	1e-06	1.03e-05	CbGpPWpGaD
Dopamine—HTR7—Signaling Pathways—IL6—hematologic cancer	9.99e-07	1.03e-05	CbGpPWpGaD
Dopamine—SLC22A2—Metabolism—PIK3CA—hematologic cancer	9.95e-07	1.02e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—EP300—hematologic cancer	9.93e-07	1.02e-05	CbGpPWpGaD
Dopamine—CYP2C19—Metabolism—PIK3R1—hematologic cancer	9.9e-07	1.02e-05	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—MYC—hematologic cancer	9.85e-07	1.01e-05	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—TGFB1—hematologic cancer	9.83e-07	1.01e-05	CbGpPWpGaD
Dopamine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	9.74e-07	1e-05	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—PIK3CA—hematologic cancer	9.73e-07	1e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—SRC—hematologic cancer	9.65e-07	9.93e-06	CbGpPWpGaD
Dopamine—CYP2D6—Metabolism—PIK3CD—hematologic cancer	9.64e-07	9.92e-06	CbGpPWpGaD
Dopamine—MAOA—Metabolism—AKT1—hematologic cancer	9.61e-07	9.89e-06	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—PIK3CA—hematologic cancer	9.6e-07	9.87e-06	CbGpPWpGaD
Dopamine—DRD4—Signaling Pathways—IL6—hematologic cancer	9.57e-07	9.84e-06	CbGpPWpGaD
Dopamine—CYP2C9—Metabolism—PIK3CD—hematologic cancer	9.56e-07	9.83e-06	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—KRAS—hematologic cancer	9.52e-07	9.79e-06	CbGpPWpGaD
Dopamine—CYP2D6—Metabolism—ALB—hematologic cancer	9.52e-07	9.79e-06	CbGpPWpGaD
Dopamine—CYP2C9—Metabolism—ALB—hematologic cancer	9.44e-07	9.71e-06	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—TP53—hematologic cancer	9.41e-07	9.68e-06	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—VEGFA—hematologic cancer	9.4e-07	9.67e-06	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—STAT3—hematologic cancer	9.31e-07	9.58e-06	CbGpPWpGaD
Dopamine—CYP1A2—Metabolism—PIK3CG—hematologic cancer	9.29e-07	9.56e-06	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—NRAS—hematologic cancer	9.29e-07	9.56e-06	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—TP53—hematologic cancer	9.28e-07	9.55e-06	CbGpPWpGaD
Dopamine—SLC22A1—Metabolism—PIK3CA—hematologic cancer	9.27e-07	9.54e-06	CbGpPWpGaD
Dopamine—HTR7—Signaling Pathways—AKT1—hematologic cancer	9.22e-07	9.49e-06	CbGpPWpGaD
Dopamine—CYP2C19—Metabolism—PIK3CB—hematologic cancer	9.14e-07	9.4e-06	CbGpPWpGaD
Dopamine—CYP2D6—Metabolism—PIK3R1—hematologic cancer	9.1e-07	9.37e-06	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—KRAS—hematologic cancer	9.1e-07	9.37e-06	CbGpPWpGaD
Dopamine—CYP2C9—Metabolism—PIK3R1—hematologic cancer	9.03e-07	9.29e-06	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—HRAS—hematologic cancer	9e-07	9.26e-06	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—MAPK3—hematologic cancer	8.89e-07	9.15e-06	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—HRAS—hematologic cancer	8.88e-07	9.14e-06	CbGpPWpGaD
Dopamine—DRD4—Signaling Pathways—AKT1—hematologic cancer	8.83e-07	9.08e-06	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—PIK3CA—hematologic cancer	8.74e-07	9e-06	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—MYC—hematologic cancer	8.65e-07	8.9e-06	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—TGFB1—hematologic cancer	8.63e-07	8.88e-06	CbGpPWpGaD
Dopamine—CYP1A2—Metabolism—CREBBP—hematologic cancer	8.61e-07	8.86e-06	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—IL6—hematologic cancer	8.61e-07	8.86e-06	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—IL6—hematologic cancer	8.5e-07	8.74e-06	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—TP53—hematologic cancer	8.46e-07	8.7e-06	CbGpPWpGaD
Dopamine—CYP2D6—Metabolism—PIK3CB—hematologic cancer	8.4e-07	8.65e-06	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—PIK3CA—hematologic cancer	8.36e-07	8.61e-06	CbGpPWpGaD
Dopamine—CYP2C9—Metabolism—PIK3CB—hematologic cancer	8.33e-07	8.57e-06	CbGpPWpGaD
Dopamine—CYP1A2—Metabolism—PIK3CD—hematologic cancer	8.17e-07	8.4e-06	CbGpPWpGaD
Dopamine—SLC22A2—Metabolism—AKT1—hematologic cancer	8.13e-07	8.36e-06	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—TP53—hematologic cancer	8.09e-07	8.33e-06	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—HRAS—hematologic cancer	8.09e-07	8.32e-06	CbGpPWpGaD
Dopamine—CYP1A2—Metabolism—ALB—hematologic cancer	8.06e-07	8.3e-06	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—KRAS—hematologic cancer	7.99e-07	8.22e-06	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—AKT1—hematologic cancer	7.95e-07	8.18e-06	CbGpPWpGaD
Dopamine—CYP2C19—Metabolism—PTEN—hematologic cancer	7.9e-07	8.12e-06	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—AKT1—hematologic cancer	7.84e-07	8.07e-06	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—IL6—hematologic cancer	7.74e-07	7.97e-06	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—HRAS—hematologic cancer	7.74e-07	7.96e-06	CbGpPWpGaD
Dopamine—CYP1A2—Metabolism—PIK3R1—hematologic cancer	7.71e-07	7.94e-06	CbGpPWpGaD
Dopamine—SLC22A1—Metabolism—AKT1—hematologic cancer	7.58e-07	7.8e-06	CbGpPWpGaD
Dopamine—CYP2C19—Metabolism—EP300—hematologic cancer	7.53e-07	7.75e-06	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—IL6—hematologic cancer	7.41e-07	7.62e-06	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—PIK3CA—hematologic cancer	7.34e-07	7.56e-06	CbGpPWpGaD
Dopamine—CYP2D6—Metabolism—PTEN—hematologic cancer	7.26e-07	7.47e-06	CbGpPWpGaD
Dopamine—CYP2C9—Metabolism—PTEN—hematologic cancer	7.2e-07	7.41e-06	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—AKT1—hematologic cancer	7.14e-07	7.35e-06	CbGpPWpGaD
Dopamine—CYP1A2—Metabolism—PIK3CB—hematologic cancer	7.12e-07	7.32e-06	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—TP53—hematologic cancer	7.1e-07	7.31e-06	CbGpPWpGaD
Dopamine—CYP2D6—Metabolism—EP300—hematologic cancer	6.93e-07	7.13e-06	CbGpPWpGaD
Dopamine—CYP2C9—Metabolism—EP300—hematologic cancer	6.87e-07	7.06e-06	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—AKT1—hematologic cancer	6.83e-07	7.03e-06	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—HRAS—hematologic cancer	6.79e-07	6.99e-06	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—IL6—hematologic cancer	6.5e-07	6.69e-06	CbGpPWpGaD
Dopamine—CYP1A2—Metabolism—PTEN—hematologic cancer	6.15e-07	6.33e-06	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—AKT1—hematologic cancer	6e-07	6.17e-06	CbGpPWpGaD
Dopamine—CYP1A2—Metabolism—EP300—hematologic cancer	5.87e-07	6.04e-06	CbGpPWpGaD
Dopamine—CYP2C19—Metabolism—PIK3CA—hematologic cancer	5.57e-07	5.73e-06	CbGpPWpGaD
Dopamine—CYP2D6—Metabolism—PIK3CA—hematologic cancer	5.12e-07	5.27e-06	CbGpPWpGaD
Dopamine—CYP2C9—Metabolism—PIK3CA—hematologic cancer	5.08e-07	5.23e-06	CbGpPWpGaD
Dopamine—CYP2C19—Metabolism—AKT1—hematologic cancer	4.55e-07	4.68e-06	CbGpPWpGaD
Dopamine—CYP1A2—Metabolism—PIK3CA—hematologic cancer	4.34e-07	4.47e-06	CbGpPWpGaD
Dopamine—CYP2D6—Metabolism—AKT1—hematologic cancer	4.18e-07	4.31e-06	CbGpPWpGaD
Dopamine—CYP2C9—Metabolism—AKT1—hematologic cancer	4.15e-07	4.27e-06	CbGpPWpGaD
Dopamine—CYP1A2—Metabolism—AKT1—hematologic cancer	3.55e-07	3.65e-06	CbGpPWpGaD
